LabCorp Denver 8490 Upland Drive

1 d CO 80 11 2 7 1 I -LabCorp E PI 800 795 3699 l<~boratory Corporo:.tio n of Amtrie~ ngtewoo , - ) 1one: - -Specimen !'\umber I Patient iD Control Number I Account Number

I Accomlt Phone Ntunber

I Route

PatiemLast Name Account Addres'i

Direct Laboratory Servi ces LLC Patient First Name I Patient Middle Name I nterface Acct

Patient SS#

I Patient Phone Total Volume 404 0 Florida Street Suite 202

Mandeville LA 70448 Age (Y/WD) I DateofBinh I Sex Fasting

Patient Address Additional Infonuation

Date: and Time: Collc:ctcd .I Datc: Enh:red I Date and Time: Rc:pot1t:d Physic ian Kam~ I NPI I Physician ID

Tests O rdered

CMP14+LP+TP+TSH+5AC+CBC/D/Plt; Urinalysis, Complete; Hgb Al e with eAG Estimation ; Testost e r one, Free and Total; DHEA- Sulfate; Estradiol; C-Reactive Protei n, Cardiac ; Homocyst(e) ine, Plasma ; Fibrinogen Activi ty; Drawi n g Fee

General Comments

ACC : PID:

I TESTS RESULT FLAG UNITS REFERENCE I NTERVAL CMP14 +LP+TP+TSH+SAC+CBC/ D/ Pl t Chemistr i es

Glu cose, Serum Uric Ac i d , Serum Please Note:

BUN Creat i n i ne , Serum eGFR If NonAfri c n Am eGFR If Africn Am BUN/Creat i n i ne Ratio Sodium, Serum Potuss i urn, Serum Chloride, Serum Carbon Dioxide, Total Calci um, Serum Phosph orus , Serum Protein, Total , Serum Al bumi n, Serum Globul i n , Total A/G Rat i o Bilirubin , To t al Al kaline Phosphatase, LDH AST (SGOT)

ALT (SGPT) GGT Iron, Serum

Lipids Cholesterol, Total

09/29/1 2 1 0 :17 ET

s

83 4. 8

mg/ d L mg/ dL

65 - 99 2.5- 7.1

Therapeut i c 9

0.75

pat ients : <6 .0 6 - 24

0 . 57- 1. 00

target for gout mg/ dL mg/ d L

mL/ min/ 1 . 73 mL/ min/ 1. 73

92 106

12 143 4.0 105

23 9 . 2 3. 1 6.4 4. 3 2 . 1 2. 0 1.3

67 1 74

67 151

26 120

1 70

High

Hi gh Hi gh

FI NAL REPORT

mmol / L mmol / L mmol / L mmol/L mg/ dL mg / dL g / dL g / d L g / dL

mg/ dL IU/ L I U/ L I U/ L I U/ L I U/ L

ug/ dL

mg/ dL

>5 9 >5 9

9 - 23 134 - 144 3 .5 - 5 . 2

97 - 108 20 - 32

8.7 10.2 2.5 - 4.5 6 . 0 - 8 . 5 3 .5 - 5 . 5 1.5 - 4 . 5 1. 1 - 2 . 5 0 .0 - 1. 2

25 - 150 0 - 214 0 - 40 0 - 4 0 0 - 60

35 - 155

100 - 199

Page 1 of 4

LAB I

01 01 01 01

01 01

01 01 01 01 01 01 01 01

01 01 01 01 01 01 01 01 01 01

This document contains private etnd coufidential health information protected by state and fedeml law.

If you have received this document in en or, please call 5 0 4 - 8 2 8 - 2 6 6 6 ©2004- 12 Labort~ IOI)' Corporfltion of America ® Ho ldings

All Rights Rese1ved DOC! Ver: 1.49

LabCorp Laboratory Corporat ion of Amerlc.:l

Accotmt Number I TESTS

Triglyce r i des

HDL Ch o lesterol Commen t

Patient lO

Accordi ng t o ATP-III neg a t i v e r isk f ac t or

LDL Cholesterol Ca l c

T. Chol/HDL Ratio

Thyro id TSH Thyroxine (T4) T3 Uptak e Fre e Thyroxine I ndex

CBC , Plate l et Ct , and Di ff WBC RBC Hemogl obin Hemat ocri t MCV MCH MCHC ROW Platelets Ne utroph il s Lymphs Monocy t e s Eo s Basos Ne u trophi ls (Absol ute) Lymphs (Absolute ) Mon ocytes(Absol u t e ) Eos (Absol ute ) Ba so (Absolute ) I mma t u r e Granul ocytes I mmatur e Gr a ns (Abs )

Ur i nalys is, Comp lete Urina l ys i s Gr oss Exam

Specific Gr a v i t y pH Uri ne- Col o r Appeara nce WBC Esteras e

09/29/1 2 1 0 : 1 7 ET

LabCorp Denver 8490 Upland Drive

Englewood, CO 80 117- 7115 Patient Name

Phone: S00-795-3699 SJ>ecimen Number

I Control Number

I Date and Time Collected I Date Reported Sex I Age(YIM/D)

I Date of Bi11b

RESULT FLAG **Please note

58 **Pl e ase note

69

Guidelines, HDL- C >59 for CHD .

8 9 **Please note 2.5

0 . 038 15 . 5

32 5.0

8.2 4.56 14.2 4 2 . 1

92 31. 1 33.7 12 . 4

250 55 36

5 3 1

4 . 5 2 . 9 0 .4 0 . 3 0 . 1

0 0 . 0

1. 004 7 . 0

Yellow Clea r

Negat i v e

Low Hi gh

High

Low

FINAL REPORT

UNITS REFERENCE INTERVAL reference interval chang e **

mg/ d L 0 - 149 referen ce interval chang e * *

mg/ d L >39

mg / d L is cons i der e d a

mg/dL 0 - 99 r e f e rence i nterval c h ange** ratio units

uiU/ mL ug/d L

%

x10E3 / uL X1 0E6/uL

g / dL %

f L pg

g / dL

x10E3 / u L %

%

x 1 0E3/uL x 10E3 / u L X1 0E3 / uL x10E3 / uL x10E3 / uL

% x 10E3/ uL

0.0 - 4 . 4

0 . 450 - 4 . 50 0 4 . 5 - 12 . 0

24 - 3 9 1 . 2 - 4 . 9

4 . 0 - 10 . 5 3 . 77 - 5 . 28 11 .1 - 15.9 34 . 0 - 4 6 . 6

79 - 97 26 . 6 - 33 . 0 31.5 - 35.7 12 . 3 - 15 .4

140 - 415 40 - 74 14 - 4 6

4 - 13 0 - 7 0 - 3

1 . 8 - 7 . 8 0 . 7 - 4 . 5 0 .1 - 1. 0 0 . 0 - 0 . 4 0 . 0 - 0 . 2

0 - 2 0 . 0 - 0 . 1

1. 005 - 1 . 03 0 5.0 - 7.5

Yell ow Clear

Negat i v e

P a g e 2 o f 4

LAB I

01

01 01

01 01 01 01 01

01 01 01 01 01 01 01 01 01 01 01 01 01 01 01 01 01 01 01 01 01 01 01

01 01 01 01 01 01

Thi~ do(.'Umeu t ~:uul aiu~ p1-ivult! aml l'un fidcu tial h!!al th iufonuatiou J.>rUit!L'Ied by ::;tale aud [!;;!denll law .

If you have received this document in en-or. please call 50 4 - 8 2 8 - 2 6 6 6

©2004- 12 LaLuntlory Cuq xuatiou uf Alul'ric.:a ® Holdiug::s

All Rights Resetv ed DOC ! Ver: 1.49

rilon ffiiHI

Accotmt Nmuber I Patient iD

I

LabCorp Denver 8490 Up land Drive

En<>lewood CO RO 112- 7 11 ~ c

Pati~ut Ncuuc

Control Number

I Date and Time Collected I Date Repo11ed

TESTS RESULT FLAG UNITS

Protei n Glu cose Ketones Occult Blood

Negat i v e Negative Negat i ve Negative Negative Bilirubi n

Urobil i nogen,Semi-Qn Nitrite, Ur i ne Microscopic Examinat i on

0 . 2 Negative

mg / dL

Mi croscop ic f ollows Microscopic Examinat i on WBC

i f ind i cated . See below :

0-5 RBC None seen Epithelial Cells (non renal) 0-1 0 Bac ter i a None seen

Hgb Al e wi t h eAG Estimation Hemoglobin Al e 5.2

I ncreased r i sk for d i abetes : 5 . 7 - 6.4 Diabetes: >6 . 4

/ hpf / hpf / hpf

%

Phone· S00-795-3699 - ' Sp~cimcu Nmnbcr

Sex I Age(YIM/D)

I Date of Bi11h

REFERENCE I NTERVAL LAB I Nega tiv e / Trace 01

Ne g a t i ve 01 Negat i ve 01 Neg a t ive 01 Negat i ve 01 0.0 - 1. 9 01 Neg a t ive 01

01 01

0 - 5 01 0 - 3 01 0 - 1 0 01

Non e seen/ Few 01

4.8 - 5 . 6 01

Glycemic control for adults with diabetes : <7 . 0 Estim. Avg Gl u (eAG ) 103 mg / dL

Tes tos terone , Free a nd Tota l Te s t oste rone , Se rum 25 ng/ dL 3 - 41 01 Free Testosterone (Di r ect ) 0 . 2 pg/ mL 0 . 0 - 2 . 2 02

DHEA-Sulfat e 251.0 ug/ dL 35.4 - 256 . 0 01

Es tradiol 58 . 8 pg / mL 01 Adult Female :

Fol l i cul ar phase 12 . 5 - 166 . 0 Ovul a t ion phase 85 . 8 - 4 98. 0 Lutea l p hase 4 3 . 8 - 2 11 . 0 Postmenopa usal <6 . 0 - 54 . 7

Pr egnancy 1st trimester 215 . 0 - :>4 3 00 . 0

Gi rls (1-10 years ) 6.0 - 27 . 0 Roche ECLIA methodol ogy

09 / 2 9/12 1 0 : 17 ET FINAL REPORT Page 3 o f 4

This document contains private and confidential health infonnation protected by state and federal law.

If yon have received this document in en or, please call 5 0 4 - 8 2 8 - 2 6 6 6

©2004- 12 Laboratory Corporation of America ® Holdings All Rights Resetv ed

DOC! Ver: 1.49

LabCorp Denver 8490 Upland Drive

Enulewood CO 80 II?-7 115 Patient Name

Phone· 800-795- 3699 Specimen Number

Account Number I Patient ill I Control Nu mber I Date an d Time Collected I D <lt c Rcp011cd Sox I Agc(YIM/D) I Onto ofBi11b

TESTS

C-Reactive Pro tein , Cardiac

Homo c y st(e ) ine, Plasma

Fib rinog e n Ac tiv ity

RESULT FLAG UNITS REFERENCE I NTERVAL

0.41 mg / L o. oo- 3. 00 Relative Risk for Fut ure car d i ovascular Ev ent

7 . 4

324

Low Average High

umol / L

mg/ d L

<1 .00 1. 00 - 3 .0 0

>3.00

0 . 0 1 5 . 0

193 - 4 23

0 1 DV Lab Corp Denver Di r : Frank Ryan , PhD 8490 Upland Drive, Engl ewood , CO 80112 - 7115

02 BN LabCorp Burlington Dir : Wi l liam F Ha ncock, MD 14 47 York c ourt, Burlington, NC 27215- 33 6 1

For inquiri es , the phys i cian ma y c o n t act Bra nch: 800- 76 2- 4344 La b: 800- 7 95 - 3699

09/ 2 9 / 1 2 1 0 : 1 7 ET FINAL REPORT P a g e 4 o f 4

LAB I

0 1

0 1

0 1

This document contains private and confidential health infonnation protected by state and federal law. If you have received this document in en-or, please call 5 0 4 - 8 2 8 - 2 6 6 6

©2004- 12 Laboratmy Corporation of America ® Holdings All Rights Resetved

DOC! Ver: 1.49